SKP2 and breast carcinoma: To test whether diosgenin performed anticancer activity via regulation of the Skp2 signaling pathway in breast cancer cells, we conducted the rescue experiment to observe if overexpression of Skp2 would abrogate diosgenin-induced antitumor function.